CRISPR Therapeutics

55.86
+1.02
+1.86%
CRSP
高 56.68开 55.35量 328.36万股总市值 53.23亿
低 55.00换 3.45%额 1.83亿市盈TTM 亏损
分时
5日
日K
周K
月K
季K
年K
  • MA
  • BOLL
  • 成交量
  • MACD
  • KDJ
  • RSI
  • WR
  • BIAS
  • CCI
  • PSY
讨论
资讯
公告
资料
财务
相关
用户头像
CRISPR Therapeutics(CRSP)
11-15 01:35  
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000940594-25-000008  Act: 34  Size: 16 KB 网页链接
1赞
用户头像
CRISPR Therapeutics(CRSP)
11-10 21:25  
$CRISPR Therapeutics(CRSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-273337  Act: 34  Size: 9 MB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
11-10 21:15  
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-273329  Act: 34  Size: 428 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
11-05 05:55  
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-106355  Act: 34  Size: 13 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-21 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-243819  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-16 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-240437  Size: 8 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-16 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-240438  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-16 04:25  
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-25-240282  Act: 34  Size: 285 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-16 04:15  
$CRISPR Therapeutics(CRSP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-25-240259  Act: 33  Size: 3 MB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-04 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-230505  Size: 5 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-04 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-230506  Size: 5 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-04 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-230508  Size: 5 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
10-04 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-230511  Size: 5 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
09-20 05:45  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-209353  Size: 5 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
08-20 04:35  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001682019-25-000003  Size: 9 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
08-09 04:15  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001688192-25-000004  Size: 5 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
08-05 04:35  
$CRISPR Therapeutics(CRSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-25-102052  Act: 34  Size: 11 MB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
08-05 04:25  
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-102027  Act: 34  Size: 420 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
07-18 07:55  
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0002052113-25-002963  Act: 34  Size: 10 KB 网页链接
用户头像
CRISPR Therapeutics(CRSP)
07-18 05:25  
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-25-096666  Size: 9 KB 网页链接